Attributes | Values |
---|
rdf:type
| |
Description
| - Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring at diagnosis or as secondary PCL in patients with relapsed/refractory myeloma. Primary PCL is a distinct clinic-pathological entity with different cytogenetic and molecular findings. Prospective multicenter studies are required to provide revised definitions and better understanding of the pathogenesis of PCL.
- Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring at diagnosis or as secondary PCL in patients with relapsed/refractory myeloma. Primary PCL is a distinct clinic-pathological entity with different cytogenetic and molecular findings. Prospective multicenter studies are required to provide revised definitions and better understanding of the pathogenesis of PCL. (en)
|
Title
| - Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group (en)
|
skos:prefLabel
| - Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group (en)
|
skos:notation
| - RIV/61988987:17110/13:A14019UL!RIV14-MSM-17110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61988987:17110/13:A14019UL
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - plasma cell leukemia; cytogenetics; bortezomib; transplantation; myeloma; prognosis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Hájek, Roman
- Sonneveld, P.
- Dimopoulos, M. A.
- Palumbo, A.
- Anderson, K C.
- Badros, A Z.
- Blade, J.
- Caers, J.
- Cavo, M.
- Chanan-Khan, A.
- Chim, C S.
- Comenzo, R.
- Durie, B G M.
- Fantl, D.
- Fernández de Larrea, C.
- Fonseca, R.
- Kumar, S K.
- Kyle, R A.
- Lahuerta, J J.
- Landgren, O.
- LeLeu, X.
- Ludwig, H.
- Mahindra, A.
- Mazumber, A.
- Mellqvist, U-H.
- Merlini, G.
- Moreau, P.
- Noeul, A.
- Orlowski, R Z.
- Richardson, P G.
- San Miguel, J F.
- Schots, R.
- Sezer, O.
- Shah, J J.
- Usmani, S.
- Vesole, D H.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |